ALBANY, N.Y. (AP) - New York stands to receive $146 million in the national settlement with pharmaceutical giant GlaxoSmithKline Plc., which has agreed to pay $3 billion overall to settle federal and state complaints related to marketing and pricing of its drugs.
New York Attorney General Eric Schneiderman says the record recovery will go to the state's Medicaid program.
GlaxoSmithKline has agreed to pay $2 billion in damages and civil penalties and a $1 billion criminal fine nationally, settling charges it marketed certain drugs for unapproved uses.
Charges include marketing the depression drug Paxil for off-label use by children.
The company says it has changed compliance procedures.
Schneiderman's office participated in negotiations and says New York is getting the largest share among the 42 states.
The office reported record $143 million in Medicaid recoveries last year.
Date: July 3, 2012
Source: Associated Press